Skip to content

B-vitamins and treatment for large bowel cancer: a toxic relationship?

PhD defence

In short
  • 17 December 2026
  • 15.30 - 17.00 h
  • Auditorium Omnia, building 105, Wageningen Campus
  • Livestream available

Summary

Up to 80% of patients with large bowel cancer receiving chemotherapy or radiotherapy experience side-effects due to their treatment. These side-effects do not only have impact on quality of life but may also result in alterations of the treatment for large bowel cancer. B-vitamins, like folate, vitamin B6, and vitamin B12, may interact with the cancer treatment due to the treatment’s mechanism of action. However, the intake and status of B-vitamins is often overlooked during cancer treatment. In this thesis, I aimed to unravel the role of B-vitamins in treatment tolerance in patients with large bowel cancer. Deficient and excess concentrations of folate, vitamin B6 and B12 increase the risk of side-effects of chemotherapy. Excess concentrations are likely the consequence of dietary supplement use, which is common in patients with large bowel cancer. Optimizing blood levels of B-vitamins before and during cancer treatment may be an important future strategy within oncology care.  

PhD candidate

The candidate of the PhD defence "B-vitamins and treatment for large bowel cancer: a toxic relationship?".

About the PhD defence

Date

Thu 17 December 2026
15:30 - 17:00

Organisational unit

Nutrition and Disease, VLAG, Wageningen University & Research

Room

Auditorium

External Promotor(s)

Dr. J. McKay, Northumbria University